Exact Mass: 209.1328

Minoxidil

C9H15N5O (209.1277)

C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DC - Pyrimidine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D - Dermatologicals KEIO_ID M035; [MS2] KO009058 KEIO_ID M035

Minoxidil

C9H15N5O (209.1277)

Minoxidil is only found in individuals that have used or taken this drug. It is a potent direct-acting peripheral vasodilator (vasodilator agents) that reduces peripheral resistance and produces a fall in blood pressure. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)Minoxidil is thought to promote the survival of human dermal papillary cells (DPCs) or hair cells by activating both extracellular signal-regulated kinase (ERK) and Akt and by preventing cell death by increasing the ratio of BCl^-2/Bax. Minoxidil may stimulate the growth of human hairs by prolonging anagen through these proliferative and anti-apoptotic effects on DPCs. Minoxidil, when used as a vasodilator, acts by opening adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells. This vasodilation may also improve the viability of hair cells or hair follicles. C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DC - Pyrimidine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D - Dermatologicals

2,5-Dimethoxy-4-ethylphenethylamine

C12H19NO2 (209.1416)

2,5-Dimethoxy-4-methylamphetamine

C12H19NO2 (209.1416)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

4-(2-(Ethylamino)propyl)-2-methoxyphenol

C12H19NO2 (209.1416)

Bamethan

C12H19NO2 (209.1416)

C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AA - 2-amino-1-phenylethanol derivatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

2-[Bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol

C8H19NO5 (209.1263)

Mirogabalin

C12H19NO2 (209.1416)

3-Tigloyloxynortropane

C12H19NO2 (209.1416)

AK-49175

C9H15N5O (209.1277)

2C-G

C12H19NO2 (209.1416)

2C-E

C12H19NO2 (209.1416)

Methyl-DMA

C12H19NO2 (209.1416)

2,5-Dimethoxy-4-methylamphetamine

C12H19NO2 (209.1416)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

Nicotinoylcholine

C11H17N2O2+ (209.129)

Salicifoline

C12H19NO2 (209.1416)

N,N-Dimethylhomoveratrylamine

C12H19NO2 (209.1416)

3c-methyl-(4ar,10at,10bc)-decahydro-pyrano[2,3-g]indolizin-1-one|Elaeokanin D|Elaeokanine D

C12H19NO2 (209.1416)

Nicotinoylcholine

[C11H17N2O2]+ (209.129)

IPB_RECORD: 231; CONFIDENCE confident structure

DOM

C12H19NO2 (209.1416)

3,4-DMMA

C12H19NO2 (209.1416)

4-[2-(Diethylamino)ethoxy]phenol

C12H19NO2 (209.1416)

N-Octylmaleimide

C12H19NO2 (209.1416)

N-(3-hydroxy-1-adamantyl)acetamide

C12H19NO2 (209.1416)

3-(N-ethyl-m-toluidino)propane-1,2-diol

C12H19NO2 (209.1416)

2-(2,5-dimethoxy-3,4-dimethylphenyl)ethanamine

C12H19NO2 (209.1416)

(2-METHOXY-4-PROPENYL-PHENOXY)-ACETICACID

C12H19NO2 (209.1416)

2-ISOPROPYLAMINO-1-(2-METHOXY-PHENYL)-ETHANOL

C12H19NO2 (209.1416)

[4-[3-(dimethylamino)propoxy]phenyl]methanol

C12H19NO2 (209.1416)

1-(2,4-DIMETHYL-PHENOXY)-3-METHYLAMINO-PROPAN-2-OL

C12H19NO2 (209.1416)

Methyl 3-amino-1-adamantanecarboxylate

C12H19NO2 (209.1416)

2-(1-Adamantyl)glycine

C12H19NO2 (209.1416)

4-(4-ETHOXY-PHENYLAMINO)-BUTAN-1-OL

C12H19NO2 (209.1416)

3,4-DIETHYL-2-ETHOXYCARBONYL-5-METHYLPYRROLE

C12H19NO2 (209.1416)

n,n-bis(2-hydroxypropyl)aniline

C12H19NO2 (209.1416)

2-(3,4-dimethoxyphenyl)-2-methylpropan-1-amine

C12H19NO2 (209.1416)

Fepradinol

C12H19NO2 (209.1416)

D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

3-Fluoro-4-(4-methyl-1-piperazinyl)aniline

C11H16FN3 (209.1328)

Ocrilate

C12H19NO2- (209.1416)

D001697 - Biomedical and Dental Materials > D014014 - Tissue Adhesives

3,4-DIPROPOXYANILINE HYDROCHLORIDE

C12H19NO2 (209.1416)

4-AMINO-5-IODO-2-(TRIFLUOROMETHYL)-BENZENECARBONITRILE

C12H19NO2 (209.1416)

2-[(MESITYLMETHYL)THIO]ETHYLAMINE

C12H19NS (209.1238)

tert-butyl 3-ethynylpiperidine-1-carboxylate

C12H19NO2 (209.1416)

1-Boc-2-Ethynylpiperidine

C12H19NO2 (209.1416)

2-(Cyclopropylmethyl)hexahydrocyclopenta[c]-pyrrole-3a(1H)-carboxylic acid

C12H19NO2 (209.1416)

1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-1,2,3-triazole

C9H16BN3O2 (209.1336)

UNII:6SVX956NTQ

C12H19NO2 (209.1416)

2-(1-adamantyl)-N-hydroxyacetamide

C12H19NO2 (209.1416)

Bis-tris methane

C8H19NO5 (209.1263)

D019995 - Laboratory Chemicals > D002021 - Buffers COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

2-ISOPROPOXY-3-TRIMETHYLSILANYL-PYRIDINE

C11H19NOSi (209.1236)

Phenol,2-[(diethylamino)methyl]-4-methoxy-

C12H19NO2 (209.1416)

(R)-2-(2-(3-AMINOPROPYL)PHENOXY)PROPAN-1-OL

C12H19NO2 (209.1416)

3-methoxy-N-[(4-methoxyphenyl)methyl]propan-1-amine

C12H19NO2 (209.1416)

Ethanol, 2-[[1-(4-ethoxyphenyl)ethyl]amino]- (9CI)

C12H19NO2 (209.1416)

tert-butyl 4-ethynylpiperidine-1-carboxylate

C12H19NO2 (209.1416)

3-methoxy-N-[(3-methoxyphenyl)methyl]propan-1-amine

C12H19NO2 (209.1416)

N,N-Dimethyl-2-(2-phenoxyethoxy)ethanamine

C12H19NO2 (209.1416)

DEXTRAN

C8H19NO5 (209.1263)

Methyl cis-4-AMino-1-AdaMantane Carboxylate

C12H19NO2 (209.1416)

Enantiomer of Mirogabalin

C12H19NO2 (209.1416)

2-((2-hydroxyethyl)amino)-1-(p-tolyl)propan-1-ol

C12H19NO2 (209.1416)

Glycine tricyclo[3.3.1.1(3,7)]dec-1-yl ester

C12H19NO2 (209.1416)

1-(3,4-DIETHOXY-PHENYL)-ETHYLAMINE

C12H19NO2 (209.1416)

[3-[3-(dimethylamino)propoxy]phenyl]methanol

C12H19NO2 (209.1416)

tert-butyl 2-prop-2-ynylpyrrolidine-1-carboxylate

C12H19NO2 (209.1416)

N-ethylglucamine

C8H19NO5 (209.1263)

3,4-Diethoxyphenethylamine

C12H19NO2 (209.1416)

(4-METHOXY-BENZYL)-(2-METHOXY-1-METHYL-ETHYL)-AMINE

C12H19NO2 (209.1416)

{2-[3-(Dimethylamino)propoxy]phenyl}methanol

C12H19NO2 (209.1416)

N-(2,2-diethoxyethyl)aniline

C12H19NO2 (209.1416)

tert-butyl 3,4,5-trimethyl-1H-pyrrole-2-carboxylate

C12H19NO2 (209.1416)

Mirogabalin

C12H19NO2 (209.1416)

N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BF - Gabapentinoids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

2-Octyl cyanoacrylate

C12H19NO2 (209.1416)

D001697 - Biomedical and Dental Materials > D014014 - Tissue Adhesives

[6-Aminomethyl-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acid

C12H19NO2 (209.1416)

5,5-Dimethyl-3-(morpholin-4-yl)cyclohex-2-en-1-one

C12H19NO2 (209.1416)

Silanamine, N-((4-methoxyphenyl)methyl)-1,1,1-trimethyl-

C11H19NOSi (209.1236)

Aniline, N-[2-(trimethylsiloxy)ethyl]-

C11H19NOSi (209.1236)

2-phenoxy-N-trimethylsilylethanamine

C11H19NOSi (209.1236)

1-Carboxyethylaminomethyl-4-Aminomethylbenzene

C11H17N2O2+ (209.129)

Bamethan

C12H19NO2 (209.1416)

C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AA - 2-amino-1-phenylethanol derivatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Trimethyl-[2-(pyridine-3-carbonyloxy)ethyl]azanium

C11H17N2O2+ (209.129)

(1E,3S,4Z)-7-amino-1-[3-[(E)-prop-1-enyl]oxiran-2-yl]hepta-1,4-dien-3-ol

C12H19NO2 (209.1416)

N,N-diethyl-4-methoxy-1-pyridin-1-iumcarboxamide

C11H17N2O2+ (209.129)

Phenethylamine, p-(trimethylsiloxy)-

C11H19NOSi (209.1236)

Pyridine, 2-(3-trimethylsilyloxypropyl)-

C11H19NOSi (209.1236)

2-Phenyl-2-trimethylsiloxyethylamine

C11H19NOSi (209.1236)

(3S,4R)-3-ethyl-4-[(3-methyl-1H-imidazol-3-ium-4-yl)methyl]-2-oxolanone

C11H17N2O2+ (209.129)

n-(2-methylpropyl)-3-(3-oxocyclopent-1-en-1-yl)propanimidic acid

C12H19NO2 (209.1416)

8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enoate

C12H19NO2 (209.1416)

2-(dimethylamino)-7,9-dimethyl-8h-purin-6-ol

C9H15N5O (209.1277)

(1r,3s,5s)-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C12H19NO2 (209.1416)

trimethyl[2-(pyridine-3-carbonyloxy)ethyl]azanium

[C11H17N2O2]+ (209.129)